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Summary
Objective: The hypothesis of this study is that changes in ﬂuid dynamics in subchondral bone bear a functional relationship to bone remodeling
and cartilage breakdown in osteoarthritis (OA). We have utilized dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) to ex-
tract kinetic parameters of bone perfusion at various stages in the development of OA in the DunkineHartley guinea pig.
Design: Animals of four different ages (6, 9, 12 and 15 months), representing various stages in the development of OA, were studied. All
animals underwent DCE MRI and perfusion data were analyzed based on the Brix two-compartment pharmacokinetic model. Regions of in-
terest were studied at the medial and lateral tibial plateaus and compared to histologicalehistochemical scores of articular cartilage and sub-
chondral bone plate thickness.
Results: A decrease in perfusion as well as outﬂow obstruction was observed in animals between 6 and 9 months of age, only in the medial
tibial plateau subchondral bone. The eventual cartilage and bone lesions of OA occurred also in the medial tibia. Changes in perfusion oc-
curred in the lateral tibia but not until OA lesions were established. Kinetic parameters of inﬂow were unchanged in both the medial and lateral
plateaus.
Conclusions: DCE MRI can be used to extract kinetic information on bone perfusion in an animal model of OA. The signal enhancement in
subchondral bone temporally precedes and spatially localizes at the same site of the eventual bone and cartilage lesions. Timeeintensity
curves suggest outﬂow obstruction as an underlying mechanism.
Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
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Despite decades of study, the relationships between sub-
chondral bone pathology and cartilage breakdown in osteo-
arthritis (OA) are still unclear. Osteocytes are highly
responsive to their physicochemical microenvironment
and change their cytokine expression proﬁles in response
to pressure, ﬂuid ﬂow, and hypoxia. Therefore, it is particu-
larly topical to understand changes in the physical microen-
vironment of subchondral bone in OA that may result in
altered osteocyte metabolism. This study explores temporal
and spatial relationships among perfusion, bone remodel-
ing, and cartilage degradation in OA using the Dunkine
Hartley guinea pig model of spontaneous OA of the knee.
The DunkineHartley guinea pig develops OA of the knee
that bears histological and biochemical resemblance to hu-
man OA with lesions appearing predominantly on the me-
dial side of the joint1e3. Increased subchondral bone
density and cartilage degradation occur in the medial tibial
plateau at about 12 months of age and are well established
by 15 months of age4.*Address correspondence and reprint requests to: Roy K. Aaron,
Department of Orthopaedics, Brown Medical School, 100 Butler
Drive, Providence, RI 02906, USA. Tel: 1-401-274-9660; Fax: 1-
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1350We have utilized dynamic contrast-enhanced (DCE)
magnetic resonance imaging (MRI) with gadolinium
diethylene triamine pentaacetic acid (Gd-DTPA) in the Dun-
kineHartley model to extract kinetic parameters of bone
perfusion at several stages in the development of OA.
Gd-DTPA-enhanced MRI has been used to measure perfu-
sion in brain, heart, and several neoplasms. In the skeleton,
it has been used to measure perfusion in bone tumors and
to quantitate inﬂammatory synovitis5,6. Gd-DTPA-enhanced
MRI has been correlated with 99Tc-labeled nanocolloid scin-
tigraphy uptake in early rheumatoid arthritis of the wrist7.
Gd-DTPA-enhanced MRI has been validated for bone per-
fusion in several studies of normal and abnormal bone8e12.
Our study, reported here is, to our knowledge, the ﬁrst to
use DCE MRI with Gd-DTPA prospectively in an animal
model of OA and to correlate observations on perfusion pat-
terns with the histopathology of developing OA. This study
describes temporal and spatial perfusion patterns in sub-
chondral bone and compares them with developing carti-
lage and bone lesions of OA.MethodsANIMAL PROCEDURESDCE MRI of the guinea pig knee joint in the anesthetized animal was per-
formed according to our institutionally approved protocol. In order to study
Fig. 1. The Brix pharmacokinetic model, in which kel is the elimina-
tion rate constant and kep is the rate constant between the extracel-
lular and interstitial compartments. Inﬂow is characterized by two
parameters, the slope and the amplitude.
1351Osteoarthritis and Cartilage Vol. 17, No. 10the spectrum of OA, we selected animals of four different ages (6, 9, 12, and
15 months) based on the documented timing of OA development13,14. For
each time point, six animals were studied, all acquired from the Charles River
Laboratories facility in Raleigh, NC. Birthdates, ages, and weights of all an-
imals were recorded. Central jugular venous catheters were placed by
Charles River Laboratories in order to ensure reliable venous access for
Gd-DTPA perfusion studies. In preparation for MRI scanning, guinea pigs
were anesthetized using 1e3% isoﬂurane for maintenance.
Following imaging, animals were sacriﬁced and knees obtained for histo-
chemistry and quantitative measurements of joint morphology. Tibias were
decalciﬁed and embedded in parafﬁn, and 5 mm coronal sections were ob-
tained through the OA lesion or through the middle third of the tibial plateau
if no lesions were present. Bones were stained with Safranin-O/Fast Green.
Cartilage lesions were scored according to the histologicalehistochemical
method of Mankin et al.15. Scores range from 0 (denoting no arthritis) to
14 (denoting severe changes). We have used the Mankin score in a previous
study of 26 18-month-old animals whose mean score was 11.7 0.2. Intra-
observer variability was 6.8%, and interobserver variability was 8.2%4. The
widths of the medial and lateral tibial plateaus were individually measured
with a microscopic grid and the subchondral bone plate thickness was mea-
sured at the central third of each of the medial and lateral tibial plateaus us-
ing Scion/NIH image analysis. In our laboratories from animals of 4e12
months of age, an increase in thickness of 18% with increasing age and
OA was observed. These measurements are in agreement with previous
studies using a variety of assessment techniques, including quantitative his-
tomorphometry, microcomputed tomography, and MRI14,16,17. Intraobserver
variability was 6.2%, and interobserver variability was 8.8%.IMAGING PROCEDURESAll studies were performed on a 3.0 Tesla GE MRI Scanner. Animals were
placed in a custom-designed apparatus, a 7-turn, 3.2-cm-diameter induc-
tively coupled solenoidal coil. Axial and coronal T1-weighted spin echo im-
ages were obtained with a 4 cm ﬁeld of view (FOV), 256 256 matrix,
2 mm slice thickness, a 400 ms repetition time (TR), and a 14 ms echo
time (TE). A fast spin-echo short T1 inversion-recovery (STIR) series was
taken for visualization of bone marrow edema. The slice prescription
matched that of the coronal T1-weighted series and used 6650/180/45 ms
TR/inversion time (TI)/TE. The DCE perfusion sequence was a fast multi-
plane spoiled gradient echo sequence (FMPSPGR) with 4e7 slices,
a 256 128 matrix, a 20 ﬂip angle and a 12.1/3.8 ms TR/TE. The time res-
olution varied from 6.5 to 9.6 s/image depending on whether 4e7 slices were
acquired. These sampling times are consistent with suggested requirements
that the Nyquist criterion be fulﬁlled for times related to the inverse of kpe/ve
or 1/kep
18. In all perfusion studies, the central venous line was used to intro-
duce the Gd-DTPA (Bayer Healthcare Pharmaceuticals Inc., Wayne, New
Jersey). The contrast agent was injected at a concentration of 0.3 mmol/kg
and diluted with normal saline to yield ﬁnal injection volumes between 1
and 3 ml, depending upon the weight of the animal. The rate of infusion
was 0.5e1 ml/s, placing the total injection time within a single imaging frame.
The perfusion sequence was run with ﬁve baseline scans prior to contrast in-
jection to examine image quality and placement. Following online reconstruc-
tion, data were exported to a Dell 3.4 GHz Pentium 4 PC for analysis using
in-house software written to display and analyze the data using IDL 6.0 (ITT
Visual, Boulder, CO).MRI ANALYSIS METHODSPerfusion data were analyzed using previously published in-house soft-
ware yielding parameters based on the Brix two-compartment pharmacoki-
netic model5,19,20. The Brix model describes the kinetics of Gd-DTPA
exchange between the plasma and interstitial space and is characterized
by several rate and volume transfer constants (Fig. 1). Regions of interest
(ROIs) consisted of the entire medial and lateral tibial plateaus, selected
on the T1-weighted series and then automatically overlaid on the perfusion
images for analysis of identical voxels. Signal intensities within the ROI
were averaged to generate a timeeintensity curve, which was then ﬁtted
to equation21:
SðtÞ
S0
 1þAkep

ekep t  ekel t 
kel  kep
where S0 is the baseline signal intensity prior to contrast injection and S(t) is
the signal intensity as a function of time beginning at 0 s and going to con-
clusion of the scan.
Three parameters were obtained from the compartmental ﬁt of the
timeeintensity curve within each voxel: amplitude (A), rate constant (kep),
and elimination constant (kel). The terms slope and Akep characterize perfu-
sion into the tibial plateau region. The amplitude of the ﬁt, A, is a constant
containing information about the relaxivity and dose of the contrast agent,
the proton density of the tissue, the T1 relaxation time of the tissue prior tocontrast and the extravascular extracellular space (ve). The rate constant be-
tween the plasma and tissue compartments, kep, represents a ratio of the
permeability surface area product to the size of the extravascular extracellu-
lar space (ve). The product of Akep reﬂects an estimate of the permeability
surface area of the vasculature and represents the perfusion into the region
of interest. At short times after injection, the equation may be approximated
by (1þ Akept) resulting in the initial slope of the uptake being proportional to
Akep
21. The elimination or washout of contrast from the ROI is represented
by the parameter kel and describes perfusion out of the region, or outﬂow ob-
struction. A negative value of kel indicates that the timeeintensity curve is still
enhancing and has not reached a plateau by the end of the scan time
(w5 min). It does not imply a negative physiological clearance rate of the
contrast from the system.
The model ﬁts result in an accurate description of the timeeintensity
curves as determined by the Pearson correlation coefﬁcient and allows com-
parison of curves between different ages of animals. To estimate the repro-
ducibility of the ﬁtting procedure, random noise was added to
a representative timeeintensity curve taken from the medial tibial plateau
in a 6-month-old animal at levels of 5%, 10%, 15% and 20% and the curve
repeatedly ﬁtted 100 times at each noise level. Variations in A and kel were
less than 1% and that of kep was less than 3% over the complete range of
noise levels in comparison with the initial ﬁt parameters. The addition of ran-
dom noise at a level of greater than 20% to the timeeintensity curve was not
expected given consistency in acquisition parameters, hardware and place-
ment of ROIs.STATISTICAL METHODSResults are expressed as meanþ/ the standard error of the mean (S.E.M.)
and compared for signiﬁcancewith parametric and non-parametric tests as ap-
propriate. Data sets were tested for normality. The KruskaleWallis test fol-
lowed by a two-tailed non-parametric Bonferroni-type correction was used
for multiple comparisons between 6 month and older animals. This test is
a non-parametric equivalent of a one-way analysis of variance (ANOVA) and
was appropriate to the sample size. If signiﬁcant, the ManneWhitney U test
was then used for direct comparison between two speciﬁc groups. This non-
parametric test was used for sample sizes of less than 20 that were not nor-
mally distributed. A two-tailed non-directional P-value was obtained from the
test results indicating statistical signiﬁcance only when P< 0.05.ResultsMORPHOLOGYMorphological changes in the DunkineHartley guinea pig
in our laboratory are similar to those reported by other inves-
tigators and are manifested by increasing histologicalehisto-
chemical scores reﬂecting cartilage breakdown and
increasing subchondral bone plate thickness reﬂecting
bone remodeling. Bone remodeling occurs predominantly,
and earliest, at the medial tibial plateau (Fig. 2). Loss of Saf-
ranin-O staining and superﬁcial ﬁbrillations are observed in
Fig. 2. Morphologic changes in guinea pig tibias as a function of in-
creasing age. Cartilage breakdown, reﬂected in the histologicale
histochemical score, occurred between 9 and 12 months of age
(P< 0.001). The thickness of subchondral bone plate at the medial
tibial plateau increased signiﬁcantly between 9 and 12 months of
age (P¼ 0.003).
1352 J. H. Lee et al.: Dynamic contrast-enhanced MRI and OAthe medial tibia at 9 months of age, with the development of
clefts to the subchondral bone by 12 months of age. Loss of
articular cartilage in focal lesions can be seen at 15 months
of age. Signiﬁcant changes in histologicalehistochemical
scores are observed between 9 and 12 months of age. The
score at 9 months was 3.3 0.33 compared to 8.0  0.48
at 12 months (P< 0.001). Signiﬁcant increases in medial tib-
ial subchondral bone plate thickness are also observed be-
tween 9 and 12 months of age. The thickness at 9 months
was 205.0 27.66 mm compared to 270.7 7.32 mm at 12
months (P¼ 0.003). Similar OA lesions are observed in other
locations in the knee after 12 months of age.PERFUSIONPerfusion parameters are extracted from ROIs drawn at
the medial and lateral tibial plateaus. Signal intensitiesFig. 3. Timeeintensity curves from the medial tibial plateau: (A) 6 months
with kel¼ 0.06; (B) 15 months of age with established changefrom all voxels within the ROIs were averaged to generate
a single timeeintensity curve characteristic of the region.
Figure 3(A) is a representative timeeintensity curve at the
medial tibial plateau in a 6-month-old animal before mor-
phological changes of OA. The ﬁrst pass of the Gd-DTPA
bolus can be seen directly following the ﬁfth baseline point.
Signal enhancement is seen to peak at just under 2 min and
to gradually decrease over time. This indicates moderate
washout or elimination of the contrast agent from the tibial
plateau. Figure 3(B) is a representative timeeintensity
curve taken at the medial tibial plateau in a 15-month-old
animal. The ﬁrst pass of the Gd-DTPA bolus enters the tis-
sue at a time similar to that in Fig. 3(A) but continues to en-
hance without reaching a peak by the end of the 5-min
scan. This suggests an impaired washout or elimination of
the contrast agent and obstruction blocking outﬂow from
the region. Figure 4 displays average timeeintensity curves
of the groups of animals of 6 and 15 months of age ﬁtted to
the Brix model showing the close ﬁt of experimental data
and predicted values from the model. There are no differ-
ences in the inﬂow parameters, Akep and slope. The outﬂow
parameter, kel, is signiﬁcantly different between the groups
(P¼ 0.01).
The perfusion data are summarized in Table I. Inﬂow pa-
rameters (Akep and slope) were not signiﬁcantly different in
either the medial or lateral tibia and perfusion into both the
medial and lateral tibial plateaus remained constant regard-
less of the age of the animals. The outﬂow parameter, kel, in
both the lateral and medial tibial plateaus declined with age
but declined earlier (6e9 months) in the medial side. The kel
of the medial tibial plateau decreased from 0.18 0.03 at 6
months of age to 0.01 0.02 at 9 months of age
(P¼ 0.004). The kel in the lateral tibial plateau did not signif-
icantly change between 6 and 9 months of age (P¼ 0.2).
When compared to morphological indices of OA severity
(Fig. 2), it can be seen that outﬂow obstruction in the medial
tibia at 6e9 months temporally precedes both cartilage deg-
radation and bone remodeling. These observations illus-
trate the speciﬁcity of the changes in perfusion at 6e9
months in the medial tibia since they both temporally pre-
cede and spatially localize in the same medial tibia regionof age before morphologic changes of OA reveals normal perfusion
s of OA reveals diminished perfusion with kel¼0.11.
Fig. 4. Timeeintensity curves of the medial tibia in guinea pigs of 6 and 15 months of age were averaged for all animals in the cohort and
plotted with the S.E.M.. Inﬂow of the contrast material is similar as characterized by similar slope values. At 15 months of age, the outﬂow phase
is characterized by persistent signal enhancement indicating lack of clearance of the contrast agent suggesting venous outﬂow obstruction
and reduced perfusion.
1353Osteoarthritis and Cartilage Vol. 17, No. 10as the eventual cartilage and bone lesions of OA. Perfusion
declines further, and changes appear on the lateral side at
12 and 15 months, coinciding with the appearance of OA
lesions.Discussion
A relationship between bone remodeling and cartilage
degeneration in OA has been recognized for many years
but the role of subchondral bone in the pathophysiology of
OA remains elusive. Studies have focused on remodeling
in the subchondral bone that is observable by plain X-ray,
e.g., sclerosis, trabecular remodeling and osteophytes.
However, the role of the osteocytes in subchondral bone re-
modeling, and the pathophysiological relationship of bone
remodeling to cartilage degeneration in OA, continue to
be incompletely understood22e27. We have utilized the
DunkineHartley guinea pig model of spontaneous OA be-
cause longitudinal studies of bone remodeling in this model
reveal changes in subchondral bone that resemble those inTable
Perfusion parameters in
6 9
Medial Akep 0.99 0.16 min1 1.89 0.44 min
Medial slope 91.7 12.6% min1 135.3 27.7% mi
Medial kel 0.18 0.03 min1 0.01 0.02 min
Lateral Akep 1.27 0.09 min1 2.93 0.57 min
Lateral slope 113.5 18.2% min1 152.1 23.4% mi
Lateral kel 0.13 0.04 min1 0.05 0.04 min
No signiﬁcant changes were observed in the inﬂow parameters, Akep a
parameter, kel, declined signiﬁcantly on the medial side at 6 vs 9 mont
(P< 0.001). The kel on the lateral side was unchanged at 6 vs 9 month
15 months (P¼ 0.006).human OA. Three studies using different techniques, dem-
onstrate bone remodeling coincident with early cartilage
degeneration14,16,17.
The hypothesis underlying this study is that DCE MRI can
be used to detect changes in perfusion patterns in subchon-
dral bone that bear a functional relationship to bone remodel-
ing and cartilage degeneration. Signal enhancement in DCE
MRI is achieved with the use of paramagnetic contrast me-
dium such as Gd-DTPA, which causes local magnetic ﬁeld
ﬂuctuations and reduces the relaxation times, T1 and T2, of
enhancing tissues. The change in signal enhancement
over time (signal intensityetime curves) can be used to ex-
tract quantitative information concerning ﬂuid kinetics using
pharmacokinetic models. Several models, including that of
Brix, have been reviewed recently21. They are all based on
several assumptions that have been validated in many clini-
cal studies of tumors, rheumatoid synovitis, and myocardial
and bone perfusion5,6,8e12,28e30. Signal enhancement can
be linearly related to the concentration of the contrast me-
dium in both blood and tissue, and blood ﬂow can be esti-
mated from the transit time of the contrast medium5,6,21.I
the tibial plateaus
Months of age
12 15
1 1.54 0.21 min1 1.37 0.35 min1
n1 110.1 7.0% min1 96.2 15.3% min1
1 0.04 0.03 min1 0.03 0.03 min1
1 1.84 0.31 min1 2.11 0.54 min1
n1 122.7 10.4% min1 132.4 23.4% min1
1 0.01 0.01 min1 0.01 0.02 min1
nd slope, in either the medial or lateral tibial plateaus. The outﬂow
hs (P¼ 0.004); 6 vs 12 months (P¼ 0.002); and 6 vs 15 months
s (P¼ 0.2) and declined at 6 vs 12 months (P¼ 0.006) and 6 vs
1354 J. H. Lee et al.: Dynamic contrast-enhanced MRI and OABecause signal enhancement is proportional to the perfusion
of contrast medium and to blood ﬂow, changes in tissue per-
fusion can be inferred from the timeeintensity curves, espe-
cially the enhancement decay slope of the outﬂow phase
characterized by kel. Prolonged signal enhancement in the
outﬂow phase has been associated with venous outﬂow ob-
struction, stasis, and decreased perfusion38. We have mea-
sured signal enhancement and decreased perfusion
appearing earliest in medial tibial bone in guinea pigs be-
tween 6 and 9 months of age, temporally preceding and spa-
tially co-localizing with the sites of eventual cartilage and
bone lesions of OA.
Gd-MRI is a well established method of assessing perfu-
sion5e12. It has been correlated with technetium and with ra-
dioisotopes including 15O and 18F. Further, Gd-enhanced
MRI has been validated by comparison with radioactive
microspheres31,32.
Several pharmacokinetic models have been proposed to
extract kinetic information on perfusion and have been re-
viewed in several papers by Tofts21,33. All models involve
physiological assumptions and we do conclude below that
these need to be validated by direct measurements. The
Brix model used by us, has been validated in clinical and
preclinical studies 5,19,20. It is beyond the scope of this pa-
per to validate the model further. Our interpretation of the
Brix model is consistent with many other observations pro-
posing a vascular component of OA 34e38. These studies fo-
cused on venous outﬂow obstruction as a key pathological
observation. Our timeeintensity curves show clear and sig-
niﬁcant differences in the outﬂow phase of contrast admin-
istration independent of the model chosen to describe them.
Other causes of signal enhancement have been consid-
ered. The observation of signal enhancement by Gd in
OA bone is plotted as timeeintensity curves as a function
of animal age and the development of age-related OA. In-
ﬂow parameters (‘‘slope’’ and ‘‘amplitude’’) are unchanged
indicating that the delivery of Gd to bone remains constant.
The outﬂow parameter, kel, is signiﬁcantly changed as evi-
denced by the difference in the slope of the outﬂow or wash-
out phase on the timeeintensity curves. Table I presents
data showing that inﬂow parameters are unchanged in ani-
mals of various ages and stages of OA so that an enhanced
delivery of Gd does not seem to be occurring.
The intraosseous extravascular extracellular compart-
ment is complex and comprises several tissues prominently
fat, hematopoietic marrow, and bone. Gd does not have ac-
cess to all those compartments. The volume of the extra-
vascular compartment to which Gd has access, ‘‘ve’’, can
be estimated from the Tofts model. A single arterial input
function was acquired from the popliteal artery and a ﬁxed
value of vp was used for all animals. The relaxation time
(T10) prior to contrast administration of the tibial plateau
was ﬁxed at 1.35 s which remains consistent with other
measures. Using this model, the ve does not change be-
tween 6 and 9 months at either the medial or lateral tibial
plateau. This is the time period in which we observe the ma-
jor decrease in ﬂow on the medial side so the ve does not
appear to be playing a predominant role in the observed
changes in ﬂow. The ve does rise similarly in both the me-
dial and lateral sides at 12 and 15 months, as do other in-
dices of developing OA including subchondral bone
thickness, histochemical scores of cartilage, and outﬂow
obstruction in both the medial and lateral tibias. Thus at
the time period of interest, we observed kel changes in the
absence of changes in the extravascular extracellular
space, supporting our interpretation that the kel changes re-
ﬂect outﬂow obstruction, stasis, and decreased perfusion.We have also examined changes in capillary permeability
which might explain movement of Gd from the intravascular
to the extravascular space. We have used the Tofts model
to estimate the capillary permeability surface area (Ktrans).
These data indicate that transvascular movement of Gd
into the extravascular intraosseous compartment is not
preferentially occurring in pathologic bone and that signal
enhancement is independent of this mechanism.
Our studies demonstrate that DCE MRI with Gd-DTPA
can be used to extract kinetic information on bone perfusion
in OA. We have characterized the signal enhancement in
subchondral bone and have demonstrated that it temporally
precedes and spatially localizes at the same site of eventual
bone and cartilage lesions in the experimental model of
spontaneous OA in the DunkineHartley guinea pig. Since
signal enhancement is proportional to the concentration of
Gd, it may be possible to extract information on blood
ﬂow, intraosseous pressure, and pO2 that appears to be
consistent with the values observed in human OA. The
physiological implications of changes in perfusion may be
related to alterations in the physicochemical environment
in bone, particularly ﬂuid ﬂow, pressure and oxygen tension.
Osteocytes respond to these changes in ﬂuid dynamics in
their microenvironment by altering their patterns of gene ex-
pression39e42. The changes in perfusion we have observed
may be part of a physicochemical signaling mechanism to
osteocytes and may constitute a functional relationship to
bone remodeling and cartilage breakdown in OA. However,
the complexity of osseous circulatory physiology and tissue
permeability requires that these estimations be subject to
experimental validation.Conﬂict of interest
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